Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B).
D001905:Botulinum Toxins / Q000009:adverse effects*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D004348:Drug Labeling; D006801:Humans; D008666:Metalloendopeptidases; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
C096323:rimabotulinumtoxinB; D008666:Metalloendopeptidases; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A